{
  "pmcid": "8514577",
  "sha256": "24b43b347bfc766d0cab0d369414a93193e3e97279f47f5bc0cec5d0c87c5262",
  "timestamp_utc": "2025-11-09T16:18:08.701268+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.511464237516872,
    "reading_ease": 8.293988978857413,
    "word_count": 247
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This study sought to determine if intraoperative methylprednisolone during neonatal cardiac surgery is associated with neurodevelopmental outcomes at 12 months of age"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "A planned secondary analysis of a two-center, double-blind, randomized, placebo-controlled trial"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized, placebo-controlled trial of intraoperative methylprednisolone in neonates undergoing cardiac surgery"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study sought to determine if intraoperative methylprednisolone during neonatal cardiac surgery is associated with neurodevelopmental outcomes at 12 months of age"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Bayley Scales of Infant and Toddler Development-III (BSID-III) were performed at 12 months of age"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "double-blind, randomized"
      },
      "Blinding": {
        "score": 2,
        "evidence": "double-blind"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "There were 129 participants (n=61 methylprednisolone, n=68 placebo)"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "There were no significant differences in BSID-III scores and brain injury biomarker levels between the two treatment groups"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}